Objective: This study aims to evaluate the effects of a six-month treatment combining traditional Chinese medicine derived from oilseed rape pollen with finasteride on the mean curvature of the prostatic urethra (UMCP), urethral length of the prostate (ULP), thickness of the prostate and bladder neck (TPBN), testosterone/estradiol ratio (T/E), and International Prostate Symptom Score (IPSS) in patients with benign prostatic hyperplasia (BPH). The goal is to determine whether the oilseed rape pollen preparation enhances the alleviation of urinary obstruction symptoms. Methods: Sixty-two patients with urinary obstruction due to prostatic hyperplasia, who met the study’s inclusion criteria and were treated at Tongxiang Municipal Hospital of Traditional Chinese Medicine, were selected. They were randomly divided into two groups: one receiving the oilseed rape pollen preparation in combination with finasteride and the other receiving finasteride alone. Relevant indicators were measured and recorded at baseline and six months after treatment. Data were analyzed using appropriate statistical methods. Results: The combined therapy with oilseed rape pollen did not significantly reduce the mean curvature of the prostatic urethra but effectively delayed its further increase. Patients in the experimental group showed a greater increase in urethral length compared to the control group. Additionally, the thickening of the prostate and bladder neck was significantly inhibited in the experimental group. Both groups exhibited a significant increase in T/E, with no notable difference between them. IPSS scores improved significantly in both groups, with a more pronounced reduction in the experimental group. Conclusion: The combination of oilseed rape pollen-based traditional Chinese medicine and finasteride for BPH treatment can help improve posterior prostatic urethral morphology, regulate hormone levels, and enhance symptom relief. This combined approach provides notable benefits for patients with BPH.
Chinese Medical Association Gerontology Branch, Editorial Board of Chinese Journal of Geriatrics, 2015, Consensus on Drug Therapy for Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in the Elderly (2015). Chinese Journal of Geriatrics, 34(12): 1380–1387.
Liu D, Bai X, Liu G, et al., 2021, Research Progress on the Pathogenesis of Benign Prostatic Hyperplasia. Journal of Practical Clinical Medicine, 25(5): 112–117.
Chen B, Cao D, Chen Z, et al., 2020, Estrogen Regulates the Proliferation and Inflammatory Expression of Primary Stromal Cells in Benign Prostatic Hyperplasia. Transl Androl Urol, 9(2): 322–331.
Angrimani D, Brito MM, Rui BR, et al., 2020, Reproductive and Endocrinological Effects of Benign Prostatic Hyperplasia and Finasteride Therapy in Dogs. Sci Rep. 10(1): 14834.
Chen J, Hu W, Cheng B, 2012, Effects of Changes in Estrogen/Androgen Ratio on the Proliferation and Apoptosis of Prostatic Stromal Cells in Rats. Wuhan University Journal (Medical Edition), 33(05): 623–626.
Shen J, Li Y, Han N, et al., 2021, Overview of Research on Rape Bee Pollen. Shaanxi Agricultural Sciences, (7): 94–97.
Zhou Q, Ding Z, Zhang Q, et al., 2022, Research Progress and Industrial Application of Rape Flower. Today’s Pharmacy, 32(2): 91–101.
Li Z, Li L, Shi X, 2018, Research Progress on Chemical Constituents and Pharmacological Effects of Rape Bee Pollen. Gansu Medical Journal, 37(05): 394–398.
Chen X, Wu R, Ren Z, et al., 2020, Regulation of MicroRNAs by Rape Bee Pollen on Benign Prostate Hyperplasia in Rats. Andrologia, 52(1): e13386.
Chen X, Wu R, Zhu Y, et al., 2018, Study on the Inhibition of Mfn1 by Plant-Derived miR5338 Mediating the Treatment of BPH with Rape Bee Pollen. BMC Complementary and Alternative Medicine, 18(1): 38.
Zhu C, Du L, Gao Y, et al., 2011, Experimental Study on the Inhibition of Prostate Cancer Cell Growth by the Lipid-Soluble Extract of Rape Bee Pollen. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 21(2): 84–86.